Why the study?
Does increased ET1 expression in breast tumor tissue predict chemotherapy-induced cardiotoxicity in women with breast cancer?
Does increased ET1 expression in breast tumor tissue predict chemotherapy-induced cardiotoxicity in women with breast cancer?
Increased ET1 expression in breast tumor tissue may serve as a biomarker to predict chemotherapy-induced cardiotoxicity in women with breast cancer.
ET1 expression may support biomarker evaluation for cardiotoxicity risk; leaves open clinical utility pending prospective validation.
= 0.017). Increased ET1 expression in breast tumor tissue is associated with reduced LVEF. Future studies need to examine whether ET1 may be a tissue biomarker that helps predict the risk of developing CIC in women with breast cancer.
No takes yet. Share an insight, caveat, or question.
Krishnarao et al. (2022) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: